News on companies and Evangeline Lilly

RFK Jr. on Ozempic, Eli Lilly's next test, and Elon Musk gets on the bandwagon: Pharma news roundup

Read on: Quartz

Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars

Read on: CNBC News

Scoop: Trump, RFK Jr. dine with Pfizer and Lilly execs

Read on: Axios

Medicaid dominates coverage of Novo, Lilly weight-loss drugs

Read on: Fast Company

Lilly slashes prices on lowest doses of weight loss drug Zepbound

Read on: NBC News

Lilly's weight-loss drug cuts diabetes risk by 94% in three-year trial, company says

Read on: NBC News

Lilly Gains in Obesity Race With Novo as Supplies Expand

Read on: Bloomberg

FDA approves Lilly's new Alzheimer's drug after delay

Read on: The Hill

FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval

Read on: CNBC News

Evangeline Lilly announces Hollywood exit

Read on: Times of India

China Urges Lilly to Boost Investing Amid US Cutoff Threat

Read on: Bloomberg

In an unusual move, FDA postpones approval decision for Lilly's Alzheimer's drug

Read on: NBC News

Berkshire and Lilly race to shake tech's grip on trillion-dollar club

Read on: Phys

Lilly to build $2.5 billion Germany plant as obesity drug demand soars

Read on: Reuters

Lilly trades at a premium to Ozempic maker Novo as obesity drugs boom. Here's why, analyst says

Read on: CNBC News